Showing results (1251-1260 of 1,526) with videos related to
Sort By:
Pageof 153
Current Oncology (Toronto, Ont.)|December 31, 2020
Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessmentB C Tse, B I Said, Z J Fan, et al.Neuropathology and Applied Neurobiology|October 14, 2021
TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brainPinki Munot, Nadine McCrea, Silvia Torelli, et al.Optics Letters|March 1, 2022
Optical phased array neural probes for beam-steering in brain tissueWesley D Sacher, Fu-Der Chen, Homeira Moradi-Chameh, et al.Heart Rhythm|July 6, 2023
Omnipolar versus bipolar mapping to guide ventricular tachycardia ablationCiro Ascione, Christopher Kowalewski, Marco Bergonti, et al.Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.JACC. Clinical Electrophysiology|August 25, 2018
Maximal Pre-Excitation Based Algorithm for Localization of Manifest Accessory Pathways in AdultsThomas Pambrun, Rim El Bouazzaoui, Nicolas Combes, et al.Journal of the American College of Cardiology|March 11, 2017
Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial FibrillationHan S Lim, Mélèze Hocini, Remi Dubois, et al.Heart Rhythm|April 16, 2017
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic riskAntoine Andorin, Jean-Baptiste Gourraud, Jacques Mansourati, et al.Clinical Lung Cancer|June 2, 2024
Immediate Versus Deferred Systemic Therapy in Patients With MesotheliomaSabine Schmid, Luna Zhan, Miguel Garcia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancerLinda E Coate, Christine Massey, Andrew Hope, et al.Pageof 153